Umlobi: Monica Porter
Usuku Lokudalwa: 19 Hamba 2021
Ukuvuselela Usuku: 28 Hamba 2025
Anonim
Kusetshenziswa iMethotrexate Ukwelapha I-Psoriatic Arthritis - Impilo
Kusetshenziswa iMethotrexate Ukwelapha I-Psoriatic Arthritis - Impilo

-Delile

Ukubuka konke

I-Methotrexate (MTX) yisidakamizwa esisetshenziselwe ukwelapha i-psoriatic arthritis ngaphezulu kokungaphezulu. Yodwa noma ihlanganiswe nezinye izindlela zokwelapha, i-MTX ibhekwa njengokwelashwa komugqa wokuqala kwe-psoriatic arthritis (PsA) elinganiselayo. Namuhla, kuvame ukusetshenziswa ngokuhlanganiswa nemithi emisha ye-biologic ye-PsA.

I-MTX inemiphumela emibi engaba yingozi. Ngasohlangothini oluhle, i-MTX:

  • akubizi
  • kusiza ukunciphisa ukuvuvukala
  • isula izimpawu zesikhumba

Kodwa i-MTX ayivimbeli ukubhujiswa okuhlangene lapho isetshenziswa yodwa.

Xoxa nodokotela wakho ukuthi ngabe i-MTX iyodwa noma ihlanganiswe nezinye izidakamizwa kungaba yindlela enhle yokwelashwa kuwe.

Isebenza kanjani i-methotrexate njengokwelashwa kwe-psoriatic arthritis

I-MTX yisidakamizwa se-antimetabolite, okusho ukuthi siphazamisa ukusebenza okujwayelekile kwamaseli, uwavimbe ekuhlukaniseni. Ibizwa ngokuthi yisidakamizwa esiguqula isifo semishanguzo (i-DMARD) ngoba sinciphisa ukuvuvukala kwamalunga.

Ukusetshenziswa kwayo kokuqala, okwenzeka ngasekupheleni kwawo-1940, kwakusezingeni eliphakeme lokwelapha i-leukemia yengane. Ngamanani aphansi, i-MTX icindezela amasosha omzimba futhi ivimbela ukukhiqizwa kwezicubu ze-lymphoid ezibandakanyeka ku-PsA.


I-MTX yagunyazwa yi-U.S. Food and Drug Administration (FDA) ngo-1972 ukuthi isetshenziswe nge-psoriasis enamandla (okuvame ukuhlobene ne-psoriatic arthritis), kodwa futhi isetshenziswe kakhulu “off label” ye-PsA. “Ukuphuma kwelebula” kusho ukuthi udokotela wakho angakunika izifo ezingezona ezivunyelwe yi-FDA.

Ukusebenza kwe-MTX ye-PsA akukaze kufundwe ezivivinyweni ezinkulu zemitholampilo, ngokwe-American Academy of Dermatology (AAD). Esikhundleni salokho, izincomo ze-AAD ze-MTX zisuselwa kulwazi lwesikhathi eside nemiphumela yodokotela abayinikeze i-PsA.

I-athikili yokubuyekeza ka-2016 ikhombisa ukuthi akukho cwaningo lokulawulwa ngokungahleliwe olukhombise ukuthuthuka ngokuhlanganyela kwe-MTX kunaleyo ye-placebo. Isivivinyo sezinyanga eziyisithupha sango-2012 sabantu abangu-221 ezinyangeni eziyisithupha asibutholanga ubufakazi bokuthi ukwelashwa kweMTX kukodwa kuthuthukise ukuvuvukala kwamalunga (synovitis) ePsA.

Kepha kunomphumela obalulekile owengeziwe. Ucwaningo luka-2012 lwathola ukuthi ukwelashwa kwe-MTX wenze kuthuthukisa kakhulu ukuhlolwa okuphelele kwezimpawu ngabo bobabili odokotela nabantu abane-PsA ababambe iqhaza ocwaningweni. Futhi, izimpawu zesikhumba zenziwa ngcono nge-MTX.


Olunye ucwaningo, olwabikwa ngo-2008, lwathola ukuthi uma abantu abane-PsA belashwa kusenesikhathi kulesi sifo ngomthamo owandisiwe we-MTX, baba nemiphumela engcono. Kubantu abangu-59 abakucwaningo:

  • Amaphesenti angama-68 abe nokwehla kwamaphesenti angama-40 ekubalweni okuhlangene okushisayo
  • Amaphesenti angama-66 abe nokwehla kwamaphesenti angama-40 ekubhalweni kwamalungu okuvuvukala
  • Amaphesenti ama-57 abe ne-Psoriasis Area ne-Severity Index (i-PASI) ethuthukisiwe

Lolu cwaningo lwango-2008 lwenziwa emtholampilo waseToronto lapho ucwaningo lwangaphambilini lwalungatholanga nzuzo yokwelashwa kweMTX ngokuvuvukala okuhlangene.

Izinzuzo ze-methotrexate ye-psoriatic arthritis

IMTX isebenza njenge-anti-inflammatory futhi ingaba wusizo iyodwa kumacala amancane we-PsA.

Ucwaningo lwango-2015 luthole ukuthi amaphesenti angama-22 abantu abane-PsA abaphathwa kuphela nge-MTX bathole umsebenzi omncane wezifo.

I-MTX iyasebenza ekususeni ukubandakanyeka kwesikhumba. Ngalesi sizathu, udokotela wakho angaqala ukwelashwa kwakho nge-MTX. Kubiza kancane kunezidakamizwa ezintsha ze-biologic ezenziwe ekuqaleni kweminyaka yama-2000.


Kepha i-MTX ayivimbeli ukubhujiswa okuhlangene ku-PsA. Ngakho-ke uma usengozini yokubhujiswa kwamathambo, udokotela wakho angangeza kwesinye sezinto eziphilayo. Le mithi ivimbela ukukhiqizwa kwe-tumor necrosis factor (TNF), into ebangela ukuvuvukala egazini.

Imiphumela emibi ye-methotrexate ye-psoriatic arthritis

Imiphumela emibi yokusetshenziswa kwe-MTX kubantu abane-PsA ingabonakala. Kucatshangwa ukuthi izakhi zofuzo zingaphendula ngazinye ku-MTX.

Ukukhula kwengane

I-MTX yaziwa njengokulimaza ekukhuleni kwengane. Uma uzama ukukhulelwa, noma uma ukhulelwe, hlala kude ne-MTX.

Ukulimala kwesibindi

Ingozi enkulu ukulimala kwesibindi. Cishe umuntu oyedwa kwabangu-200 abathatha iMTX banomonakalo wesibindi. Kepha umonakalo ubuyela emuva uma umisa iMTX. Ngokuya ngeNational Psoriasis Foundation, ubungozi buqala ngemuva kokufinyelela ekuqongeleleni impilo yonke kwama-1.5 amagremu we-MTX.

Udokotela wakho uzoqapha ukusebenza kwesibindi sakho ngenkathi uthatha i-MTX.

Ingozi yokulimala kwesibindi iyanda uma:

  • uphuze utshwala
  • zikhuluphele
  • unesifo sikashukela
  • babe nokusebenza kwezinso okungajwayelekile

Eminye imiphumela emibi

Eminye imiphumela emibi engaba khona ayimbi kangako, ayizizwa kahle futhi imvamisa iyalawuleka. Lokhu kufaka phakathi:

  • isicanucanu noma ukuhlanza
  • ukukhathala
  • izilonda zomlomo
  • isifo sohudo
  • ukulahleka kwezinwele
  • isiyezi
  • ikhanda
  • Ukugodola
  • ingozi eyengeziwe yokutheleleka
  • ukuzwela ekukhanyeni kwelanga
  • umuzwa ovuthayo ezilondeni zesikhumba

Ukusebenzisana kwezidakamizwa

Eminye imishanguzo yezinhlungu ezithengiswa ekhawunteni njenge-aspirin (iBufferin) noma ibuprofen (Advil) ingakhuphula imiphumela emibi ye-MTX. Amanye ama-antibiotic angasebenzisana ukunciphisa ukusebenza kwe-MTX noma angaba yingozi. Khuluma nodokotela wakho ngemithi yakho kanye nokuxhumana okungenzeka ne-MTX.

Isilinganiso se-methotrexate esisetshenziselwa i-psoriatic arthritis

Umthamo wokuqala we-MTX we-PsA ngama-milligram ama-5 kuye kwayi-10 ngesonto evikini lokuqala noma amabili. Ngokuya ngempendulo yakho, udokotela uzokwengeza kancane umthamo ufike ku-15 kuye ku-25 mg ngesonto, okubhekwa njengokwelashwa okujwayelekile.

I-MTX ithathwa kanye ngesonto, ngomlomo noma ngomjovo. I-MTX yomlomo ingaba iphilisi noma ifomu eliketshezi. Abanye abantu bangahle bahlukanise umthamo ube izingxenye ezintathu ngosuku abalithatha ngalo ukusiza ngemiphumela emibi.

Udokotela wakho angaphinde anikeze isengezo se-folic acid, ngoba i-MTX yaziwa ukunciphisa amazinga abalulekile e-folate.

Ezinye izindlela ze-methotrexate ekwelapheni i-psoriatic arthritis

Kunezinye izindlela zokwelapha i-PsA kubantu abangakwazi noma abangafuni ukuthatha iMTX.

Uma une-PsA emnene kakhulu, ungakwazi ukukhulula izimpawu ngezidakamizwa ezingezona ukuvuvukala (ama-NSAID) wedwa. Kepha i-NSAIDS enezilonda zesikhumba. Kuyafana nokujova kwendawo kwama-corticosteroids, angasiza ngezimpawu ezithile.

Amanye ama-DMARD ajwayelekile

Ama-DMARD ajwayelekile eqenjini elifanayo ne-MTX yilawa:

  • i-sulfasalazine (i-Azulfidine), ezokwenza ngcono izimpawu ze-arthritic kepha ayiyeki ukulimala okuhlangene
  • leflunomide (Arava), okumele ithuthukise zombili izimpawu zokuhlangana nezesikhumba
  • i-cyclosporine (Neoral) ne-tacrolimus (Prograf), esebenza ngokuvimbela umsebenzi we-calcineurin ne-T-lymphocyte

Lawa ma-DMARDS kwesinye isikhathi asetshenziswa ngokuhlangana nezinye izidakamizwa.

I-Biologics

Imishanguzo emisha eminingi iyatholakala, kodwa le ibiza kakhulu. Ucwaningo luyaqhubeka, futhi kungenzeka ukuthi ezinye izindlela zokwelapha ezintsha zingatholakala esikhathini esizayo.

Ama-biologics avimbela i-TNF futhi anciphise ukulimala okuhlangene ku-PsA afaka lawa ma-TNF alpha-blockers:

  • i-etanercept (Enbrel)
  • i-adalimumab (Humira)
  • infliximab (i-Remicade)

Ama-biologics akhombe amaprotheni e-interleukin (ama-cytokines) anganciphisa ukuvuvukala futhi athuthukise ezinye izimpawu. Lokhu kuvunyelwe i-FDA ekwelapheni i-PsA. Kubandakanya:

  • i-ustekinumab (Stelara), i-antibody e-monoclonal ehlose i-interleukin-12 ne-interleukin-23
  • i-secukinamab (Cosentyx), ekhomba i-interleukin-17A

Enye indlela yokwelashwa i-apremilast yezidakamizwa (i-Otezla), ekhomba ama-molecule ngaphakathi kwamaseli omzimba abandakanyeka ekuvukeleni. Imisa i-enzyme phosphodiesterase 4, noma i-PDE4. I-Apremilast inciphisa ukuvuvukala nokuvuvukala okuhlangene.

Yonke imithi elapha i-PsA inemiphumela engemihle, ngakho-ke kubalulekile ukuhlola izinzuzo nemiphumela emibi nodokotela wakho.

Ukuthatha

I-MTX ingaba ukwelashwa okuwusizo kwe-PsA ngoba inciphisa ukuvuvukala futhi isiza izimpawu ngokuphelele. Futhi ingaba nemiphumela emibi kakhulu, ngakho-ke uzodinga ukubhekwa njalo.

Uma kunamalungu akho angaphezu kweyodwa, ukuhlanganisa iMTX ne-biologic DMARD kungasiza ekunqandeni ukubhujiswa okuhlangene. Xoxa nodokotela wakho ngazo zonke izindlela zokwelashwa, futhi ubuyekeze uhlelo lokwelashwa njalo. Kungenzeka ukuthi ucwaningo oluqhubekayo ngamakhambi e-PsA luzoqhamuka ngokuzayo.

Ungakuthola futhi kuwusizo ukukhuluma ne "navigator yesiguli" e-National Psoriasis Foundation, noma ujoyine elinye lamaqembu ayo okuxoxa nge-psoriasis.

Imibhalo Emisha

Ukuvalwa komzimba okunamandla - izinso

Ukuvalwa komzimba okunamandla - izinso

Ukuvalwa okunamandla kwezin o ukuvinjelwa okungazelelwe, okunzima komthambo okunikeza igazi ezin o.Izin o zidinga ukunikezwa kwegazi okuhle. Umthambo omkhulu wezin o ubizwa ngokuthi umthambo wezin o. ...
Ukusetshenziswa kotshwala nokuphuza okuphephile

Ukusetshenziswa kotshwala nokuphuza okuphephile

Ukuphuza ut hwala kubandakanya ukuphuza ubhiya, iwayini, noma ut hwala obunzima.Ut hwala bungezinye zezidakamizwa ezi et henzi wa kakhulu emhlabeni.UKUPHUZA KWABA HAUku et henzi wa kot hwala akuyona i...